# Ketamine Versus Dexmedetomidine as an Adjuvant in Scalp Block in Supratentorial Brain Tumor Excision Surgeries

> **NCT07698665** · NA · RECRUITING · sponsor: **Cairo University** · enrollment: 90 (estimated)

## Conditions studied

- Regional Anesthesia Morbidity
- Supratentorial Brain Tumor
- Acute Pain

## Interventions

- **DRUG:** Scalp Block with Bupivacaine

## Key facts

- **NCT ID:** NCT07698665
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698665, "Ketamine Versus Dexmedetomidine as an Adjuvant in Scalp Block in Supratentorial Brain Tumor Excision Surgeries". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*